Welcome to our dedicated page for Electrocore SEC filings (Ticker: ECOR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
electroCore, Inc. filings document the regulatory record of a commercial-stage bioelectronic medicine and wellness company focused on non-invasive vagus nerve stimulation products. Current reports include financial results, guidance, preliminary estimates, and business updates tied to prescription sales, VA channel activity, direct-to-consumer Truvaga sales, and Quell product revenue.
The filings also cover capital-structure and governance matters, including common stock issuances, resale registration obligations, board composition, executive changes, and related material-event disclosures. These records describe electroCore’s operating performance, product commercialization, financing activity, and public-company governance framework.